Natal, 2018
Natal, 2018
Natal, 2018
Tumor Biology
April 2018: 1–12
Ó The Author(s) 2018
Collagen analysis by second-harmonic Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
generation microscopy predicts DOI: 10.1177/1010428318770953
journals.sagepub.com/home/tub
Abstract
Second-harmonic generation microscopy represents an important tool to evaluate extracellular matrix collagen struc-
ture, which undergoes changes during cancer progression. Thus, it is potentially relevant to assess breast cancer devel-
opment. We propose the use of second-harmonic generation images of tumor stroma selected on hematoxylin and
eosin–stained slides to evaluate the prognostic value of collagen fibers analyses in peri and intratumoral areas in patients
diagnosed with invasive ductal breast carcinoma. Quantitative analyses of collagen parameters were performed using
ImageJ software. These parameters presented significantly higher values in peri than in intratumoral areas. Higher intra-
tumoral collagen uniformity was associated with high pathological stages and with the presence of axillary lymph node
metastasis. In patients with immunohistochemistry-based luminal subtype, higher intratumoral collagen uniformity and
quantity were independently associated with poorer relapse-free and overall survival, respectively. A multivariate
response recursive partitioning model determined 12.857 and 11.894 as the best cut-offs for intratumoral collagen quan-
tity and uniformity, respectively. These values have shown high sensitivity and specificity to differentiate distinct out-
comes. Values of intratumoral collagen quantity and uniformity exceeding the cut-offs were strongly associated with
poorer relapse-free and overall survival. Our findings support a promising prognostic value of quantitative evaluation of
intratumoral collagen by second-harmonic generation imaging mainly in the luminal subtype breast cancer.
Keywords
Breast cancer, second-harmonic generation, collagen fibers, tumor microenvironment, prognosis
1
Laboratory of Investigative and Molecular Pathology, Center for
7
Investigation in Pediatrics (CIPED), Faculty of Medical Sciences, State Department of Obstetrics and Gynecology, Faculty of Medical Sciences
University of Campinas, Campinas, Brazil and CAISM—Women’s Hospital, State University of Campinas,
2
Department of Anatomic Pathology, A.C. Camargo Cancer Center, São Campinas, São Paulo, Brazil
8
Paulo, Brazil Oncology Section, Department of Internal Medicine, Faculty of Medical
3
Laboratory of Experimental Pathology (LAPE), CAISM—Women’s Sciences, State University of Campinas, Campinas, São Paulo, Brazil
Hospital, State University of Campinas, Campinas, Brazil
4
Department of Quantum Eletronics, ‘‘Gleb Wataghin’’ Institute of Corresponding author:
Physics, State University of Campinas, Campinas, Brazil Luı́s Otávio Sarian, Department of Obstetrics and Gynecology, Faculty of
5
INFABIC—National Institute of Science and Technology on Photonics Medical Sciences and CAISM—Women’s Hospital, State University of
Applied to Cell Biology, Campinas, Brazil Campinas, Rua Tessália Vieira de Camargo, 126, Campinas 13083-970,
6 São Paulo, Brazil.
Department of Structural and Functional Biology, Institute of Biology,
State University of Campinas, Campinas, Brazil Email: [email protected]
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial
use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and
Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
2 Tumor Biology
stage, and presence of axillary lymph node metastasis, Fluorescent in situ hybridization (FISH), used to detect
all features related to unfavorable prognosis. More HER-2 amplification, was performed using the HER-2/
importantly, intratumoral COL quantity and unifor- neu probe (VYSIS 36-161060, Des Plaines, IL, USA).
mity in breast cancer were related to distinct outcomes Immunohistochemical typing was performed as fol-
within the luminal IHC-based subtype. lows: luminal A (ER and or PR+/HER-2–/histological
grades I or II), luminal B (ER and or PR+/HER-2–/
histological grade III), luminal-HER-2 (ER and or
Materials and methods PR+/HER-2+), HER-2-overexpression (ER–/PR–/
Patients and human tissues HER-2+), and triple-negative (ER–/PR–/HER-2–). As
the immunohistochemical expression of Ki67 is still
This cohort study used retrospective archival material subject of standardization (due to preanalytical issues,
from the Department of Pathology and patients’ data technical and assessment variations), histological grade
compilation, at the Center for Integral Attention to was used, as suggested elsewhere.22 For statistical pur-
Women’s Health (CAISM), University of Campinas poses, we combined all cases with hormone receptor
(Unicamp, São Paulo, Brazil). Invasive ductal breast expression (luminal A, luminal B, and luminal-HER-2)
cancer tissue specimens were obtained from 60 female as luminal subtype; the HER-2-overexpression and the
patients who were undergoing primary mastectomy or triple-negative were maintained as such.
quadrantectomy from January 2008 to July 2009 to
perform at least 5-year survival analyses. Exclusion
criteria comprised previous chemotherapy or radiother- SHG imaging
apy, history of other cancer types, and medical follow- The peri and intratumoral areas selected for COL
up shorter than 5 years. All subjects granted informed, assessment on H&E-stained breast cancer tissue sec-
written consent before being enrolled. The study is fully tions were examined at the National Institute of
compliant with the Declaration of Helsinki (approved Sciences and Technology on Photonics Applied to Cell
by the ‘‘Comitê de Ética em Pesquisa da Unicamp,’’ Biology (INFABiC, Unicamp). SHG microscopy was
approval number 087/2008). performed on a Zeiss LSM 780-NLO confocal system
Formalin-fixed, paraffin-embedded, and hematoxy- (Carl Zeiss AG, Göttingen, Germany) using a 40 3 /1.3
lin and eosin (H&E)-stained tissue sections obtained oil immersion EC Plan-Neofluar objective. The high
from the surgical specimens were reviewed to examine numerical aperture (1.3) was necessary to provide the
histopathological parameters as described28 and to spatial resolution to observe the fibrils. An excitation
select areas to be analyzed by SHG microscopy by two wavelength of 780 nm, with an approximately 100-fs
pathologists (J.V. and G.R.P.). Both pathologists, who width pulse at an 80 MHz repetition rate, was provided
did not perform the SHG analyses, independently by a Tsunami Ti:Sapphire laser (Spectra-Physics,
made selection of three intra and peritumoral areas. Irvine, CA, USA). Laser power in the objective lens,
Intratumoral areas corresponded to fibrosis within neo- incident on the sample, was around 80 mW, with circu-
plasia, admixed with groups of neoplastic cells; peritu- lar polarization. Acquisition time of each image was
moral areas corresponded to fibrosis at the border of around 60 s.
neoplasia, adjacent to cancer cells, at the interface with Only the SHG forward signal at 390 nm with the
non-neoplastic, morphologically normal tissue. Areas 0.55 NA—WD 26 mm condenser lens was collected. A
with inflammatory infiltrate, vessels, and elastosis were short-pass SP690 (Omega Filters, Brattleboro, VT,
avoided (Figure 1(a) and (b)). Analyses of COL para- USA) was used to filter the 780 nm excitation29 and
meters in the areas selected by each pathologist were was followed by a filter cube with a long-pass LP490 at
made separately and compared in order to circumvent 45° to avoid two photons excited fluorescence (TPEF)
selection bias. and an SP430 at 90° to filter only the SHG signal. Two
In order to avoid endogenous autofluorescence of detectors were used to capture the TPEF signals
tissue, 3% hydrogen peroxide washes were performed (photomultiplier (PMT) detector) and SHG signals
(four incubations, 30 s each). (non-descanned (NDD) detector), and only the latter
was considered for this study (Figure 2). A spectral
analysis of the emission between 350–430 nm did show
Hormonal receptor and HER-2 status that only a narrow peak at 390 nm consistent with
IHC for estrogen receptor (ER) and progesterone SHG signal appeared. TPEF eosin staining fluores-
receptor (PR) was performed using clones 1D5 and cence signal was also detected, but in the 530 nm range.
PgR 636, respectively (Dako, Carpenteria, CA, USA). We used the same procedure described by Burke
For HER-2, the polyclonal antibody A0458 (Dako) et al.1 to take into account day-to-day variations in
was used. Antigen–antibody reactions were detected optical alignments, comprising the acquisition of a nor-
using the ADVANCEä HRPSystem (Dako).28 malization factor, provided by the SHG image of a
4 Tumor Biology
Figure 1. Continued
determine the cut-off values for the COL parameters Table 1. Clinicopathological features of the 60 patients in this
for the survival analyses, a multivariate response recur- study.
sive partitioning algorithm was applied.31 Finally,
Features
Kaplan–Meier curves for RFS and OS were generated
for the significant variables, as determined by the recur- Age
sive partitioning model. Survival curves were compared Median (CR; years) 60 (33–88)
by the log-rank test. Significance was set at p \ 0.05. BMI
Median (CR; kg/m2) 28 (20–37)
Menopausal status
Yes (%) 40 (66.7)
Results No (%) 20 (33.3)
Pathological stage
Clinicopathological features I (%) 6 (10.0)
The median age of the 60 patients was 60 years (95% II (%) 28 (47.7)
III (%) 26 (43.3)
central range (CR) = 33–88 years); 40 (66.7%) patients Lymph node status
were postmenopausal, and the median BMI was Positive (%) 45 (75.0)
28 Kg/m2 (95% CR = 20–37 Kg/m2). The tumor was Negative (%) 15 (25.0)
pathological stage I in 6 (10.0%), II in 28 (47.7%), and Histological grade
III in 26 (43.3%) patients. Clinically positive axillary I (%) 3 (5.0)
II (%) 54 (55.0)
lymph nodes were found in 45 (75.0%) patients; the III (%) 3 (5.0)
remaining 15 (25.0%) patients were negative. Vascular invasion
Histological grading according to the Nottingham sys- Positive (%) 27 (45.0)
tem was I in 3 (5.0%), II in 54 (90.0%), and III in 3 Negative (%) 33 (55.0)
Lymph vessel invasion
(5.0%) patients. Lymph vessel invasion was present in
Positive (%) 18 (30.0)
18 (30.0%) patients and absent in 42 (70.0%), while Negative (%) 42 (60.0)
vascular invasion was present in 27 (45.0%) patients Perineural invasion
and absent in 33 (55.0%). Perineural invasion was pres- Positive (%) 14 (23.3)
ent in 14 (23.3%) and absent in 46 (76.7%) patients. By Negative (%) 33 (76.7)
Immunohistochemical-based subtype
IHC-based subtype (surrogate for molecular typing), Luminal (%) 43 (72.0)
43 (72.0%) patients had luminal subtype tumors (27 HER-2-overexpressing (%) 7 (11.0)
luminal A, 1 luminal B, and 15 luminal-HER-2), 7 Triple-negative (%) 10 (17.0)
(11.0%) had HER-2-overexpressing tumors, and 10 Relapse
(17.0%) had triple-negative tumors. Nine (15.0%) Yes (%) 9 (15.0)
No (%) 51 (85.0)
patients presented tumor relapse, and 7 (11.7%) died Death from disease
from disease. In one case of luminal A breast cancer, Yes (%) 7 (11.7)
follow-up data were not available (Table 1). No (%) 53 (88.3)
pcom: the level of significance comparing the parameters between peri and intratumoral collagen fibers: all parameters present significantly higher
values in peritumoral collagen. pcor: the level of significance when peri and intratumoral parameters were correlated: while quantity and uniformity
of collagen fibers increase or decrease with similar behavior in both locations, fiber organization did not show the same correlation. The data were
expressed as mean (standard deviation).
Quantity 4.127 0.031 1.135 15.010 4.127 7.838 0.017 1.446 42.480 0.031
Uniformity 3.198 0.009 1.325 7.716 3.198 1.787 0.270 0.644 4.961 0.256
Organization 4.488 0.765 EL 0.529 0.009 0.440 EL 0.497
Association with clinicopathological features When the analyses were restricted to the luminal
Higher intratumoral COL uniformity was associated breast cancer, higher intratumoral COL quantity was
with other clinical parameters related to unfavorable out- associated with an approximately eightfold increased risk
come: BMI above 30 Kg/m2 (p = 0.019), with high of death (p = 0.017; CI: 1.45–42.48) and a fourfold risk
pathological stage III (p = 0.004), and with axillary of recurrence (p = 0.031; CI: 1.14–15.01). When axillary
lymph node metastasis (p = 0.034). No other association lymph node metastasis, BMI, and pathological stage were
was found for intratumoral COL parameters. Higher included for multivariate analysis, there was still a signifi-
ratio between intra and peritumoral COL quantity was cantly higher risk of death for higher intratumoral COL
associated with BMI above 30 Kg/m2 (p = 0.036) and quantity (p = 0.031) but not with relapse (p = 0.109).
death related to disease (p = 0.048). No associations Higher intratumoral COL uniformity was associated with
were found when peritumoral COL parameters (quan- an approximately threefold increased risk of relapse
tity, uniformity, and organization) were analyzed accord- (p = 0.009; CI: 1.33–7.72); when the same other clinico-
ing to patients’ age, histological grade, pathological pathological parameters were included for multivariate
stage, IHC-based subtype, relapse, and death. analysis, higher intratumoral COL uniformity was still
significantly associated with relapse (p = 0.015; Table 3).
The multivariate response recursive partitioning model
Prognostic implication and pathological value determined the cut-off points of 12.857 (p = 0.013) and
11.894 (p = 0.036) for intratumoral COL quantity and
RFS and OS calculated with the Cox proportional intratumoral COL uniformity, respectively, for death
hazards model for the whole group of patients showed and relapse endpoints (Figure 4). Applying these cut-offs,
that no peritumoral COL parameters presented prog- 34 cases presented lower COL quantity (21 luminal A, 1
nostic value. In contrast, higher intratumoral COL uni- luminal B, and 12 luminal HER-2) and 8 cases presented
formity was associated with an approximately twofold higher (5 luminal A and 3 luminal-HER-2). For intratu-
increased risk of relapse (p = 0.043; CI: 1.02–3.92). moral COL uniformity, 35 had lower (23 luminal A, 1
When other clinicopathological parameters were luminal B and 11 luminal HER-2) and 7 had higher val-
included (axillary lymph node metastasis, BMI, patho- ues (4 luminal A and 3 luminal HER-2). Kaplan–Meier
logical stage, and molecular subtype) for a multivariate curves for death and RFS with regard to intratumoral
analysis, this significance was not observed (p = 0.219).
8 Tumor Biology
Figure 5. (a) and (b) demonstrate an unfavorable overall and relapse-free survival, respectively, in patients with intratumoral
collagen (COL) fibers quantity above 12.857. (c) and (d) demonstrate an unfavorable overall and relapse-free survival, respectively, in
patients with intratumoral COL fibers uniformity above 11.894. Cut-offs for COL quantity and uniformity were determined using a
recursive partitioning model (for details, see text).
according to the predominant element.40 Furthermore, responsibility for this outcome. The prognostic value of
it has been demonstrated that breast cancer stroma dis- COL organization was not proven in this study; only
organization could predict poor response to neoadju- quantity and uniformity presented clinical relevance.
vant chemotherapy, using H&E and Heidenhain’s It is important to emphasize that not only molecular
AZAN trichrome staining,41 but this technique could mechanisms within cancer cells respond for cancer
not identify the isolated role of COL as the major behavior.42 Among the other hallmarks of oncogenesis,
10 Tumor Biology
tumor microenvironment, its cellular and molecular images is the area occupied by cells (neoplastic, endothe-
components, as well as its three-dimensional structure lial, stromal cells). However, a previous report addressing
represent important features explaining tumor progres- this issue demonstrated that the area of the cellular com-
sion, with potential predictive and prognostic impact.43 ponent does not represent a confounding variable.53
A recent study demonstrated that breast cancer micro- The relatively small numbers of patients in each
environment, in special increased proportion of tumor group represent a limitation of this study, which war-
stroma, was associated with tumor budding, a feature rants further confirmation by independent researchers.
previously reported as indicative of unfavorable OS.44 The technique used in this study as well as the under-
In this context, high COL uniformity could be trans- standing of the physical principles required is not
lated as higher approximation of fibers,30 which was widely applied by the pathologists for now. However,
correlated with poorer RFS and OS. The presence of these novel relevant results in human specimens could
dense clusters of COL was already shown to indicate evolve to the development of more accessible instru-
increased matrix stiffness, which correlated with poor ments, as it has happened with the molecular pathol-
survival.45,46 Increased tissue rigidity or matrix stiffness ogy. These results present potential clinical value in
seems to play a significant role during tumor progres- prognostic stratification, including microenvironmental
sion, mainly by the activation of the Hippo pathway.47 features together the classical clinicopathological para-
In this case, yes-assciated protein (YAP) could regulate meters. In analogy to the inclusion of an ‘‘immuno-
the expression of the same genes in cancer-associated score’’54 to the classification of cancer, data on the
fibroblasts, like ANLN, DIAPH3 and MYL9. This tumor matrix could complete the information needed
could reinforce the circle that helps to maintain the for a given neoplasia to explain and treat tumor pro-
fibroblast phenotype, inducing matrix stiffening.47 gression and metastatization.
Moreover, high matrix stiffness promotes, in cancer In summary, our findings demonstrate that the eva-
cells, nuclear translocation of TWIST1 by releasing this luation of SHG images is a straightforward and reason-
molecule from its cytoplasmic binding G3BP2; loss of able method for the assessment of COL parameters in
G3BP2 leads to a constitutive TWIST1 nuclear locali- the ECM associated to breast cancer, which might ulti-
zation and synergizes with increasing matrix stiffness to mately be clinically useful to evaluate prognosis. This is
induce epithelial-mesenchymal transition and promote especially true for the luminal subtype breast cancer,
tumor invasion and metastasis.48 which could benefit from the inclusion of COL para-
On the other hand, studies using diverse biological meters of prognostic relevance.
specimens have shown that SHG detect primarily type
I and II COL (both form aligned fibers) and myosin
within acto-myosin complexes, but not type III and IV Acknowledgements
COL, as these do not produce adequate SHG signals Rodrigo A Natal and José Vassallo contributed equally to this
for imaging.12,49 In this context, SHG signals detected article.
in breast cancer tissue originate mostly in type I COL,
since type II COL is only deposited in metaplastic Declaration of conflicting interests
breast cancer, specifically matrix-producing breast can-
The author(s) declared no potential conflicts of interest with
cer.50 As for myosin and microtubules, only in muscles
respect to the research, authorship, and/or publication of this
and neurons they present enough organization to gen- article.
erate an SHG signal comparable to COL fibers signal.
Also, these elements can be observed mostly in the
absence of COL.51,52 Funding
SHG image analysis of COL represents a clinically The author(s) disclosed receipt of the following financial sup-
relevant and promising approach to breast pathology, port for the research, authorship, and/or publication of this
as it renders possible to distinguish diverse pathological article: The authors thank the National Institute of Science
entities.53 Our findings help to characterize the changes and Technology on Photonics Applied to Cell Biology
in the ECM associated with tumor RFS and OS. The (INFABiC) at the State University of Campinas for access to
equipment and assistance; INFABiC is co-funded by
description of COL in tumor ECM might facilitate the
Fundac xão de Amparo à Pesquisa do Estado de São Paulo
identification of tumor invasion because alterations in (FAPESP) (08/57906-3) and Conselho Nacional de
ECM parallel breast tumor relapse.1 Thus, SHG signals Desenvolvimento Cientı́fico e Tecnológico (CNPq) (573913/
could be used to (1) differentiate between healthy and 2008-0).
tumor tissues, since peri and intratumoral areas pre-
sented distinct COL parameters in this study and (2)
ORCID iD
determine tumor prognosis (RFS and OS) simultane-
ously. A problem mentioned in the evaluation of SHG Rodrigo A Natal https://orcid.org/0000-0001-7843-3314
Natal et al. 11
References 17. Provenzano PP, Inman DR, Eliceiri KW, et al. Collagen
1. Burke K, Tang P and Brown E. Second harmonic gener- density promotes mammary tumor initiation and progres-
ation reveals matrix alterations during breast tumor pro- sion. BMC Med 2008; 6: 11.
gression. J Biomed Opt 2013; 18: 31106. 18. Conklin MW, Eickhoff JC, Riching KM, et al. Aligned
2. Han X, Burke RM, Zettel ML, et al. Second harmonic collagen is a prognostic signature for survival in human
properties of tumor collagen: determining the structural breast carcinoma. Am J Pathol 2011; 178: 1221–1232.
relationship between reactive stroma and healthy stroma. 19. Burke KA, Dawes RP, Cheema MK, et al. Second-har-
Opt Express 2008; 16: 1846–1859. monic generation scattering directionality predicts tumor
3. Sund M and Kalluri R. Tumor stroma derived biomar- cell motility in collagen gels. J Biomed Opt 2015; 20:
kers in cancer. Cancer Metastasis Rev 2009; 28: 177–183. 051024.
4. Weigel MT and Dowsett M. Current and emerging bio- 20. Kakkad SM, Solaiyappan M, Argani P, et al. Collagen I
markers in breast cancer: prognosis and prediction. fiber density increases in lymph node positive breast can-
Endocr Relat Cancer 2010; 17: R245–R262. cers: pilot study. J Biomed Opt 2012; 17: 116017.
5. Bergamaschi A, Tagliabue E, Sørlie T, et al. Extracellular 21. Walsh AJ, Cook RS, Lee JH, et al. Collagen density and
matrix signature identifies breast cancer subgroups with alignment in responsive and resistant trastuzumab-treated
different clinical outcome. J Pathol 2008; 214: 357–367. breast cancer xenografts. J Biomed Opt 2015; 20: 26004.
6. Keely PJ, Wu JE and Santoro SA. The spatial and tem- 22. Goldhirsch A, Wood WC, Coates AS, et al. Strategies
poral expression of the alpha 2 beta 1 integrin and its for subtypes—dealing with the diversity of breast cancer:
ligands, collagen I, collagen IV, and laminin, suggest highlights of the St. Gallen international expert consen-
important roles in mouse mammary morphogenesis. Dif- sus on the primary therapy of early breast cancer 2011.
ferentiation 1995; 59: 1–13. Ann Oncol 2011; 22: 1736–1747.
7. Lagacé R, Grimaud JA, Schürch W, et al. Myofibroblas- 23. Voduc KD, Cheang MCU, Tyldesley S, et al. Breast can-
tic stromal reaction in carcinoma of the breast: variations cer subtypes and the risk of local and regional relapse. J
of collagenous matrix and structural glycoproteins. Clin Oncol 2010; 28: 1684–1691.
Virchows Arch A Pathol Anat Histopathol 1985; 408: 24. Yanagawa M, Ikemot K, Kawauchi S, et al. Luminal A
49–59. and luminal B (HER2 negative) subtypes of breast cancer
8. Campagnola P. Second harmonic generation imaging consist of a mixture of tumors with different genotype.
microscopy: applications to diseases diagnostics. Anal BMC Res Notes 2012; 5: 376.
Chem 2011; 83: 3224–3231. 25. Cancer Genome Atlas Network. Comprehensive molecu-
9. Campagnola PJ and Loew LM. Second-harmonic ima- lar portraits of human breast tumours. Nature 2012; 490:
ging microscopy for visualizing biomolecular arrays in 61–70.
cells, tissues and organisms. Nat Biotechnol 2003; 21: 26. Ellis MJ and Perou CM. The genomic landscape of breast
1356–1360. cancer as a therapeutic roadmap. Cancer Discov 2013; 3:
10. Zoumi A, Yeh A and Tromberg BJ. Imaging cells and 27–34.
extracellular matrix in vivo by using second-harmonic 27. Ignatiadis M and Sotiriou C. Luminal breast cancer:
generation and two-photon excited fluorescence. Proc from biology to treatment. Nat Rev Clin Oncol 2013; 10:
Natl Acad Sci U S A 2002; 99: 11014–11019. 494–506.
11. Georgiou E, Theodossiou T, Hovhannisyan V, et al. Sec- 28. Serra KP, Sarian LO, Rodrigues-Peres RM, et al. Expres-
ond and third optical harmonic generation in type I col- sion of cyclooxygenase-2 (COX-2) and p53 in neighbor-
lagen, by nanosecond laser irradiation, over a broad ing invasive and in situ components of breast tumors.
spectral region. Opt Commun 2000; 176: 253–260. Acta Histochem 2012; 114: 226–231.
12. Cox G, Kable E, Jones A, et al. 3-dimensional imaging of 29. Chen W-L, Chou C-K, Lin M-G, et al. Single-wavelength
collagen using second harmonic generation. J Struct Biol reflected confocal and multiphoton microscopy for tissue
2003; 141: 53–62. imaging. J Biomed Opt 2009; 14: 54026.
13. Adur J, Pelegati VB, de Thomaz AA, et al. Optical bio- 30. Rezakhaniha R, Agianniotis A, Schrauwen JTC, et al.
markers of serous and mucinous human ovarian tumor Experimental investigation of collagen waviness and
assessed with nonlinear optics microscopies. PLoS ONE orientation in the arterial adventitia using confocal laser
2012; 7: e47007. scanning microscopy. Biomech Model Mechanobiol 2012;
14. Adur J, Carvalho HF, Cesar CL, et al. Nonlinear optical 11: 461–473.
microscopy signal processing strategies in cancer. Cancer 31. Anchang B, Do MT, Zhao X, et al. CCAST: a model-
Inform 2014; 13: 67–76. based gating strategy to isolate homogeneous subpopula-
15. Boudaoud A, Burian A, Borowska-Wykre˛t D, et al. tions in a heterogeneous population of single cells. PLoS
FibrilTool, an ImageJ plug-in to quantify fibrillar struc- Comput Biol 2014; 10: e1003664.
tures in raw microscopy images. Nat Protoc 2014; 9: 32. Hallgren KA. Computing inter-rater reliability for obser-
457–463. vational data: an overview and tutorial. Tutor Quant
16. Provenzano PP, Eliceiri KW, Campbell JM, et al. Col- Methods Psychol 2012; 8: 23–34.
lagen reorganization at the tumor-stromal interface facili- 33. Burke K, Smid M, Dawes RP, et al. Using second harmo-
tates local invasion. BMC Med 2006; 4: 38. nic generation to predict patient outcome in solid tumors.
BMC Cancer 2015; 15: 929.
12 Tumor Biology
34. Riching KM, Cox BL, Salick MR, et al. 3D collagen 44. Gujam FJA, McMillan DC, ,Mohammed ZMA, et al.
alignment limits protrusions to enhance breast cancer cell The relationship between tumour budding, the tumour
persistence. Biophys J 2014; 107: 2546–2558. microenvironment and survival in patients with invasive
35. Brabrand A, Kariuki II, Engstrøm MJ, et al. Alterations ductal breast cancer. Br J Cancer 2015; 113: 1066–1074.
in collagen fibre patterns in breast cancer. A premise for 45. Paszek MJ, Zahir N, Johnson KR, et al. Tensional home-
tumour invasiveness? APMIS 2015; 123: 1–8. ostasis and the malignant phenotype. Cancer Cell 2005; 8:
36. Ni Y-B, Tsang JYS, Chan SK, et al. A novel 241–254.
morphologic-molecular recurrence predictive model 46. Levental KR, Yu H, Kass L, et al. Matrix crosslinking
refines traditional prognostic tools for invasive breast forces tumor progression by enhancing integrin signaling.
carcinoma. Ann Surg Oncol 2014; 21: 2928–2933. Cell 2009; 139: 891–906.
37. Mujtaba SS, Ni Y-B, Tsang JYS, et al. Fibrotic focus in 47. Calvo F, Ege N, Grande-Garcia A, et al. Mechanotrans-
breast carcinomas: relationship with prognostic para- duction and YAP-dependent matrix remodelling is
meters and biomarkers. Ann Surg Oncol 2013; 20: required for the generation and maintenance of cancer-
2842–2849. associated fibroblasts. Nat Cell Biol 2013; 15: 637–646.
38. Hasebe T, Mukai K, Tsuda H, et al. New prognostic his- 48. Wei SC, Fattet L, Tsai JH, et al. Matrix stiffness drives
tological parameter of invasive ductal carcinoma of the epithelial-mesenchymal transition and tumour metastasis
breast: clinicopathological significance of fibrotic focus. through a TWIST1-G3BP2 mechanotransduction path-
Pathol Int 2000; 50: 263–272. way. Nat Cell Biol 2015; 17: 678–688.
39. Abraham T, Kayra D, McManus B, et al. Quantitative 49. Chen X, Nadiarynkh O, Plotnikov S, et al. Second har-
assessment of forward and backward second harmonic monic generation microscopy for quantitative analysis of
three dimensional images of collagen type I matrix remo- collagen fibrillar structure. Nat Protoc 2012; 7: 654–669.
deling in a stimulated cellular environment. J Struct Biol 50. Kusafuka K, Muramatsu K, Kasami M, et al. Cartilagi-
2012; 180: 17–25. nous features in matrix-producing carcinoma of the
40. Ioachim E, Charchanti A, Briasoulis E, et al. Immuno- breast: four cases report with histochemical and immuno-
histochemical expression of extracellular matrix compo- histochemical analysis of matrix molecules. Mod Pathol
nents tenascin, fibronectin, collagen type IV and laminin 2008; 21: 1282–1292.
in breast cancer: their prognostic value and role in 51. Psilodimitrakopoulos S, Artigas D, Soria G, et al. Quan-
tumour invasion and progression. Eur J Cancer 2002; 38: titative discrimination between endogenous SHG sources
2362–2370. in mammalian tissue, based on their polarization
41. Dekker TJA, Charehbili A, Smit VT, et al. Disorganised response. Opt Express 2009; 17: 10168–10176.
stroma determined on pre-treatment breast cancer biop- 52. Campagnola PJ, Millard AC, Terasaki M, et al. Three-
sies is associated with poor response to neoadjuvant che- dimensional high-resolution second-harmonic generation
motherapy: results from the NEOZOTAC trial. Mol imaging of endogenous structural proteins in biological
Oncol 2015; 9: 1120–1128. tissues. Biophys J 2002; 82: 493–508.
42. Hanahan D and Weinberg RA. Hallmarks of cancer: the 53. Ambekar R, Lau T-Y, Walsh M, et al. Quantifying col-
next generation. Cell 2011; 144: 646–674. lagen structure in breast biopsies using second-harmonic
43. Herrmann D, Conway JRW, Vennin C, et al. Three- generation imaging. Biomed Opt Express 2012; 3:
dimensional cancer models mimic cell-matrix interactions 2021–2035.
in the tumour microenvironment. Carcinogenesis 2014; 54. Galon J, Mlecnik B, Bindea G, et al. Towards the intro-
35: 1671–1679. duction of the ‘‘Immunoscore’’ in the classification of
malignant tumours. J Pathol 2014; 232: 199–209.